Pioneering Precision: How UMass Amherst Researchers Are Reworking Ablation Technology to Revolutionize Bladder Cancer Treatment
Executive Overview Bladder cancer remains one of the most stubborn, pervasive, and clinically challenging malignancies in modern oncology. Characterized by high rates of post-treatment recurrence—affecting up to 80% of patients—the…